Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair

Yufang Shi, Gangzheng Hu, Juanjuan Su, Wenzhao Li, Qing Chen, Peishun Shou, Chunliang Xu, Xiaodong Chen, Yin Huang, Zhexin Zhu, Xin Huang, Xiaoyan Han, Ningxia Xie, Guangwen Ren

Research output: Contribution to journalReview article

307 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) have great potential for treating various diseases, especially those related to tissue damage involving immune reactions. Various studies have demonstrated that MSCs are strongly immunosuppressive in vitro and in vivo. Our recent studies have shown that un-stimulated MSCs are indeed incapable of immunosuppression; they become potently immunosuppressive upon stimulation with the supernatant of activated lymphocytes, or with combinations of IFN-γ with TNF-α, IL-1α or IL-1Β. This observation revealed that under certain circumstances, inflammatory cytokines can actually become immunosuppressive. We showed that there is a species variation in the mechanisms of MSC-mediated immunosuppression: immunosuppression by cytokine-primed mouse MSCs is mediated by nitric oxide (NO), whereas immunosuppression by cytokine-primed human MSCs is executed through indoleamine 2, 3-dioxygenase (IDO). Additionally, upon stimulation with the inflammatory cytokines, both mouse and human MSCs secrete several leukocyte chemokines that apparently serve to attract immune cells into the proximity with MSCs, where NO or IDO is predicted to be most active. Therefore, immunosuppression by inflammatory cytokine-stimulated MSCs occurs via the concerted action of chemokines and immune-inhibitory NO or IDO produced by MSCs. Thus, our results provide novel information about the mechanisms of MSC-mediated immunosuppression and for better application of MSCs in treating tissue injuries induced by immune responses.

Original languageEnglish (US)
Pages (from-to)510-518
Number of pages9
JournalCell Research
Volume20
Issue number5
DOIs
StatePublished - May 1 2010
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Immunosuppression
Indoleamine-Pyrrole 2,3,-Dioxygenase
Cytokines
Immunosuppressive Agents
Nitric Oxide
Interleukin-1
Chemokines
Leukocytes
Lymphocytes

Keywords

  • Immune diseases
  • Immunosuppression
  • MSCs
  • Tissue repair

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Shi, Y., Hu, G., Su, J., Li, W., Chen, Q., Shou, P., ... Ren, G. (2010). Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair. Cell Research, 20(5), 510-518. https://doi.org/10.1038/cr.2010.44

Mesenchymal stem cells : A new strategy for immunosuppression and tissue repair. / Shi, Yufang; Hu, Gangzheng; Su, Juanjuan; Li, Wenzhao; Chen, Qing; Shou, Peishun; Xu, Chunliang; Chen, Xiaodong; Huang, Yin; Zhu, Zhexin; Huang, Xin; Han, Xiaoyan; Xie, Ningxia; Ren, Guangwen.

In: Cell Research, Vol. 20, No. 5, 01.05.2010, p. 510-518.

Research output: Contribution to journalReview article

Shi, Y, Hu, G, Su, J, Li, W, Chen, Q, Shou, P, Xu, C, Chen, X, Huang, Y, Zhu, Z, Huang, X, Han, X, Xie, N & Ren, G 2010, 'Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair', Cell Research, vol. 20, no. 5, pp. 510-518. https://doi.org/10.1038/cr.2010.44
Shi, Yufang ; Hu, Gangzheng ; Su, Juanjuan ; Li, Wenzhao ; Chen, Qing ; Shou, Peishun ; Xu, Chunliang ; Chen, Xiaodong ; Huang, Yin ; Zhu, Zhexin ; Huang, Xin ; Han, Xiaoyan ; Xie, Ningxia ; Ren, Guangwen. / Mesenchymal stem cells : A new strategy for immunosuppression and tissue repair. In: Cell Research. 2010 ; Vol. 20, No. 5. pp. 510-518.
@article{bf6d0996736e4f028b94d28dcfad50c5,
title = "Mesenchymal stem cells: A new strategy for immunosuppression and tissue repair",
abstract = "Mesenchymal stem cells (MSCs) have great potential for treating various diseases, especially those related to tissue damage involving immune reactions. Various studies have demonstrated that MSCs are strongly immunosuppressive in vitro and in vivo. Our recent studies have shown that un-stimulated MSCs are indeed incapable of immunosuppression; they become potently immunosuppressive upon stimulation with the supernatant of activated lymphocytes, or with combinations of IFN-γ with TNF-α, IL-1α or IL-1Β. This observation revealed that under certain circumstances, inflammatory cytokines can actually become immunosuppressive. We showed that there is a species variation in the mechanisms of MSC-mediated immunosuppression: immunosuppression by cytokine-primed mouse MSCs is mediated by nitric oxide (NO), whereas immunosuppression by cytokine-primed human MSCs is executed through indoleamine 2, 3-dioxygenase (IDO). Additionally, upon stimulation with the inflammatory cytokines, both mouse and human MSCs secrete several leukocyte chemokines that apparently serve to attract immune cells into the proximity with MSCs, where NO or IDO is predicted to be most active. Therefore, immunosuppression by inflammatory cytokine-stimulated MSCs occurs via the concerted action of chemokines and immune-inhibitory NO or IDO produced by MSCs. Thus, our results provide novel information about the mechanisms of MSC-mediated immunosuppression and for better application of MSCs in treating tissue injuries induced by immune responses.",
keywords = "Immune diseases, Immunosuppression, MSCs, Tissue repair",
author = "Yufang Shi and Gangzheng Hu and Juanjuan Su and Wenzhao Li and Qing Chen and Peishun Shou and Chunliang Xu and Xiaodong Chen and Yin Huang and Zhexin Zhu and Xin Huang and Xiaoyan Han and Ningxia Xie and Guangwen Ren",
year = "2010",
month = "5",
day = "1",
doi = "10.1038/cr.2010.44",
language = "English (US)",
volume = "20",
pages = "510--518",
journal = "Cell Research",
issn = "1001-0602",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Mesenchymal stem cells

T2 - A new strategy for immunosuppression and tissue repair

AU - Shi, Yufang

AU - Hu, Gangzheng

AU - Su, Juanjuan

AU - Li, Wenzhao

AU - Chen, Qing

AU - Shou, Peishun

AU - Xu, Chunliang

AU - Chen, Xiaodong

AU - Huang, Yin

AU - Zhu, Zhexin

AU - Huang, Xin

AU - Han, Xiaoyan

AU - Xie, Ningxia

AU - Ren, Guangwen

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Mesenchymal stem cells (MSCs) have great potential for treating various diseases, especially those related to tissue damage involving immune reactions. Various studies have demonstrated that MSCs are strongly immunosuppressive in vitro and in vivo. Our recent studies have shown that un-stimulated MSCs are indeed incapable of immunosuppression; they become potently immunosuppressive upon stimulation with the supernatant of activated lymphocytes, or with combinations of IFN-γ with TNF-α, IL-1α or IL-1Β. This observation revealed that under certain circumstances, inflammatory cytokines can actually become immunosuppressive. We showed that there is a species variation in the mechanisms of MSC-mediated immunosuppression: immunosuppression by cytokine-primed mouse MSCs is mediated by nitric oxide (NO), whereas immunosuppression by cytokine-primed human MSCs is executed through indoleamine 2, 3-dioxygenase (IDO). Additionally, upon stimulation with the inflammatory cytokines, both mouse and human MSCs secrete several leukocyte chemokines that apparently serve to attract immune cells into the proximity with MSCs, where NO or IDO is predicted to be most active. Therefore, immunosuppression by inflammatory cytokine-stimulated MSCs occurs via the concerted action of chemokines and immune-inhibitory NO or IDO produced by MSCs. Thus, our results provide novel information about the mechanisms of MSC-mediated immunosuppression and for better application of MSCs in treating tissue injuries induced by immune responses.

AB - Mesenchymal stem cells (MSCs) have great potential for treating various diseases, especially those related to tissue damage involving immune reactions. Various studies have demonstrated that MSCs are strongly immunosuppressive in vitro and in vivo. Our recent studies have shown that un-stimulated MSCs are indeed incapable of immunosuppression; they become potently immunosuppressive upon stimulation with the supernatant of activated lymphocytes, or with combinations of IFN-γ with TNF-α, IL-1α or IL-1Β. This observation revealed that under certain circumstances, inflammatory cytokines can actually become immunosuppressive. We showed that there is a species variation in the mechanisms of MSC-mediated immunosuppression: immunosuppression by cytokine-primed mouse MSCs is mediated by nitric oxide (NO), whereas immunosuppression by cytokine-primed human MSCs is executed through indoleamine 2, 3-dioxygenase (IDO). Additionally, upon stimulation with the inflammatory cytokines, both mouse and human MSCs secrete several leukocyte chemokines that apparently serve to attract immune cells into the proximity with MSCs, where NO or IDO is predicted to be most active. Therefore, immunosuppression by inflammatory cytokine-stimulated MSCs occurs via the concerted action of chemokines and immune-inhibitory NO or IDO produced by MSCs. Thus, our results provide novel information about the mechanisms of MSC-mediated immunosuppression and for better application of MSCs in treating tissue injuries induced by immune responses.

KW - Immune diseases

KW - Immunosuppression

KW - MSCs

KW - Tissue repair

UR - http://www.scopus.com/inward/record.url?scp=77952094325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952094325&partnerID=8YFLogxK

U2 - 10.1038/cr.2010.44

DO - 10.1038/cr.2010.44

M3 - Review article

C2 - 20368733

AN - SCOPUS:77952094325

VL - 20

SP - 510

EP - 518

JO - Cell Research

JF - Cell Research

SN - 1001-0602

IS - 5

ER -